Found 17 matching trials
Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine PHASE1 The purpose of this study is to evaluate the safety and immune response to ...
Show More Location
Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS
Learn More & Join Trial
Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study PHASE1 To address the critical scientific gaps in PrEP safety for transgender yout...
Show More Location
University of Colorado, Denver
Learn More & Join Trial
Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected Adults PHASE1 The purpose of this study is to determine whether TLR-9 adjuvanted pneumoco...
Show More Location
Department of Infectious Diseases, Aarhus University Hospital
Learn More & Join Trial
POC Strategies to Improve TB Care in Advanced HIV Disease NA Tuberculosis (TB) remains the major cause of morbidity and mortality among ...
Show More Location
Korle Bu Teaching Hospital
Learn More & Join Trial
Egrifta Replacement and Sleep Disordered Breathing N/A Sleep-disordered breathing is characterized primarily by partial or total u...
Show More Location
Johns Hopkins Sleep Disorders Center
Learn More & Join Trial
Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Demonstration Project NA To address the critical scientific gaps in PrEP safety for transgender yout...
Show More Location
John H. Stroger, Jr. Hospital of Cook County
Learn More & Join Trial
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV PHASE1 This phase I trial studies the best dose and effects of NT-I7 in treating K...
Show More Location
Zuckerberg San Francisco General Hospital
Learn More & Join Trial
Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE PHASE3 Treatment of facial lipoatrophy with dermal injections polylactic acid (New...
Show More Location
Hôpital Saint-Louis Service des Maladies Infectieuses
Learn More & Join Trial
Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants PHASE1 A phase 1/2a clinical trial to evaluate the safety and immunogenicity of AL...
Show More Learn More & Join Trial
Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV NA Smokers living with HIV represent a major health disparity population in th...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial